High-fiber diets and immunotherapy response
Platform for Innovative Microbiome and Translational Research
Jennifer Wargo, M.D., MMSc
PRIME-TR Director
Nadim Ajami, Ph.D.
Executive Director for Scientific Research
- Departments, Labs and Institutes
- Research Centers and Programs
- Platform for Innovative Microbiome and Translational Research (PRIME-TR)
PRIME-TR aims to position MD Anderson as a pioneer in transforming cancer therapy through the modulation of the human microbiome
The focus of the Platform for Innovative Microbiome and Translational Research (PRIME-TR) is to enable and support high-impact, microbiome-based profiling and interventional trials with the goal of understanding microbe-host interactions in the context of cancer onset, progression and response to treatment.
The goal of PRIME-TR is to build a robust framework that enables a concerted effort for translational research by leveraging existing resources at our institution and by developing programs and relationships to support novel translational applications in the microbiome space. Our ultimate goal is to improve prevention, diagnosis, and treatment strategies for cancer patients and the at-risk population. Succeeding at this vision would result in the ability to treat a wider patient population via novel and improved strategies based upon microbiome applications.
Click to enlarge
News & Media
-
August 18, 2023
Jennifer Wargo Receives 2023 Jack & Beverly Randall Prize
MD Anderson Cancer Center
-
April 19, 2023
Fecal Microbiota Transplants: 10 Questions, Answered
MD Anderson Cancer Center
-
February 15, 2023
MD Anderson Team Using Poop to Develop Cancer Treatment
Houston Chronicle
-
February 1, 2023
MD Anderson and Federation Bio Announce Collaboration to Develop Novel Microbiome Treatment
Press Release
-
January 17, 2022
MD Anderson’s Jennifer Wargo Receives TAMEST O’Donnell Award for Pioneering Microbiome Research
MD Anderson Cancer Center
-
September 26, 2022
Mighty Bugs: Your Gut Microbes Can Help Fight Cancer, New Research Reveals
Inverse.com
-
Spring 2022
The Human Microbiome: A New Dimension & Hallmark of Cancer
The National Community Oncology Dispensing Association (NCODA)
-
March 14, 2022
Could Cancer's Microbiome Help Diagnose and Treat the Disease?
The Scientist, March 2022, Issue 2
-
January 13, 2022
The PQI Podcast (Season 2, Episode 1): "Cancer and the Microbiome"
The National Community Oncology Dispensing Association (NCODA)
-
October 7, 2021
The Role of the Gut Microbiome in Colorectal Cancer
Fight Colorectal Cancer, "Beyond Blue Food" Issue
-
August 10, 2020
Over $1 Million Awarded to MD Anderson Cancer Center for Transformative Translational Research
The Mark Foundation for Cancer Research
Contact
Email: primetr@mdanderson.org
Jennifer Wargo, M.D., M.M.Sc.
PRIME-TR Director
Nadim Ajami, Ph.D.
Executive Director for Scientific Research
Jillian Losh, Ph.D.
Scientific Project Director
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.